Notice of Award of a Single-Source Cooperative Agreement To Fund the National AIDS Control Program, Programme National de Lutte contre le VIH/SIDA (PNLS), Democratic Republic of Congo, 6550 [2022-02411]

Download as PDF 6550 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices health policies under the control of Ministry of Health through the GHS Governing Council. GHS has the Mandate to provide and manage comprehensive and accessible health services with special emphasis on primary health care at regional, district, and sub-district levels. Summary of the Award Recipient: Ghana Health Service. Purpose of the Award: The purpose of this award is to build laboratory and SI capacity to improve the provision of HIV testing, treatment, and retention in line with HIV epidemic control and 95– 95–95 targets. This award strives to build and strengthen laboratories with the appropriate diagnostic technologies, trained and skilled staff, and systems that can provide efficient services. It also strengthens SI systems, data quality assurance, and the capacity of staff responsible for managing facility-based, survey, and surveillance data operating at national and subnational levels. Amount of Award: The approximate year 1 funding amount will be $800,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. Dated: February 1, 2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–02410 Filed 2–3–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund the National AIDS Control Program, Programme National de Lutte contre le VIH/SIDA (PNLS), Democratic Republic of Congo Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. lotter on DSK11XQN23PROD with NOTICES1 AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $500,000 for SUMMARY: VerDate Sep<11>2014 18:50 Feb 03, 2022 Jkt 256001 Year 1 of funding to the Programme National de Lutte contre le VIH/SIDA (PNLS). The award will strengthen Strategic Information (SI) activities, laboratory quality assurance services, and surveillance of new infections in Democratic Republic of Congo (DRC). This support will enhance the antiretroviral therapy (ART) cohort monitoring and delivery of HIV/AIDS services for the epidemic control in DRC. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Kaee Ross, Center for Global Health, Centers for Disease Control and Prevention, U.S. Embassy DRC, 498 Ave Col Lukusa, Kinshasa, Gombe, DRC, Telephone: 800–232–6348, email: knr6@ cdc.gov. SUPPLEMENTARY INFORMATION: The single-source award will improve data collection and analysis to produce a factual basis for evaluation and improvement of the HIV prevention, care, and treatment program in the DRC. The project will build capacity in DRC to have available, reliable data transmitted promptly for decisionmaking. Furthermore, the project will sustain quality assurance for rapid tests to ensure accuracy of results, and the monitoring of rapid tests used in the field. The PNLS is a specialized program run by the Ministry of Health (MOH) in the DRC. Created on August 5, 2015 by Ministerial Decision No. 449/MSLS/ CAB, the PNLS has been authorized and tasked to lead and coordinate the fight against the HIV/AIDS epidemic to achieve epidemic control. The PNLS is the governmental authority with the normative and regulatory role in the implementation of STI and HIV/AIDS control activities in the Health Zones (HZ). The PNLS has the authority to organize, review, and validate all data relative to HIV–AIDS in country. In addition, PNLS has the mission to control the quality of rapid test results provided by health care workers at facilities and to monitor how rapid tests are working in the field. Accordingly, PNLS has the sole authority and is uniquely qualified to perform the anticipated activities for this award. Summary of the Award Recipient: the Programme National de Lutte contre le VIH/SIDA (PNLS). Purpose of the Award: The purpose of this award is to strengthen SI activities, laboratory quality assurance services, and surveillance of new infections in PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 DRC. Support from this award will enhance ART cohort monitoring and delivery of HIV/AIDS services for control of the epidemic in DRC. Amount of Award: The approximate year 1 funding amount will be $500,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the availability of funds. Funding amounts for years 2–5 will be set at continuation. Authority: This program is authorized under Public Law 108–25 (the United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act of 2003). Period of Performance: September 30, 2022 through September 29, 2027. Dated: February 1,2022. Terrance Perry, Chief Grants Management Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–02411 Filed 2–3–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Single-Source Cooperative Agreement To Fund the Sierra Leone Ministry of Health and Sanitation Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $450,000 for Year 1 of funding to the Sierra Leone (SL) Ministry of Health and Sanitation. The award will build laboratory and Strategic Information (SI) capacity to improve the provision of HIV testing, treatment, and retention in line with HIV epidemic control and 95–95– 95(95% of HIV-positive individuals knowing their status, 95% of those receiving ART [Antiretroviral therapy], and 95% of those achieving viral suppression) targets. Funding amounts for years 2–5 will be set at continuation. DATES: The period for this award will be September 30, 2022 through September 29, 2027. FOR FURTHER INFORMATION CONTACT: Trong Ao, Center for Global Health, Centers for Disease Control and Prevention, CDC Ghana Office, U.S. Embassy, 24 Fourth Circular Road Cantonments, Accra, Ghana, Telephone: 800–232–6348, Email: tfa8@cdc.gov. SUMMARY: E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02411]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the National AIDS Control Program, Programme National de Lutte contre 
le VIH/SIDA (PNLS), Democratic Republic of Congo

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $500,000 for Year 1 of funding to the Programme 
National de Lutte contre le VIH/SIDA (PNLS). The award will strengthen 
Strategic Information (SI) activities, laboratory quality assurance 
services, and surveillance of new infections in Democratic Republic of 
Congo (DRC). This support will enhance the antiretroviral therapy (ART) 
cohort monitoring and delivery of HIV/AIDS services for the epidemic 
control in DRC. Funding amounts for years 2-5 will be set at 
continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Kaee Ross, Center for Global Health, 
Centers for Disease Control and Prevention, U.S. Embassy DRC, 498 Ave 
Col Lukusa, Kinshasa, Gombe, DRC, Telephone: 800-232-6348, email: 
[email protected].

SUPPLEMENTARY INFORMATION: The single-source award will improve data 
collection and analysis to produce a factual basis for evaluation and 
improvement of the HIV prevention, care, and treatment program in the 
DRC. The project will build capacity in DRC to have available, reliable 
data transmitted promptly for decision-making. Furthermore, the project 
will sustain quality assurance for rapid tests to ensure accuracy of 
results, and the monitoring of rapid tests used in the field.
    The PNLS is a specialized program run by the Ministry of Health 
(MOH) in the DRC. Created on August 5, 2015 by Ministerial Decision No. 
449/MSLS/CAB, the PNLS has been authorized and tasked to lead and 
coordinate the fight against the HIV/AIDS epidemic to achieve epidemic 
control. The PNLS is the governmental authority with the normative and 
regulatory role in the implementation of STI and HIV/AIDS control 
activities in the Health Zones (HZ). The PNLS has the authority to 
organize, review, and validate all data relative to HIV-AIDS in 
country. In addition, PNLS has the mission to control the quality of 
rapid test results provided by health care workers at facilities and to 
monitor how rapid tests are working in the field. Accordingly, PNLS has 
the sole authority and is uniquely qualified to perform the anticipated 
activities for this award.

Summary of the Award

    Recipient: the Programme National de Lutte contre le VIH/SIDA 
(PNLS).
    Purpose of the Award: The purpose of this award is to strengthen SI 
activities, laboratory quality assurance services, and surveillance of 
new infections in DRC. Support from this award will enhance ART cohort 
monitoring and delivery of HIV/AIDS services for control of the 
epidemic in DRC.
    Amount of Award: The approximate year 1 funding amount will be 
$500,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: February 1,2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02411 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.